[Toxoplasmic lymphadenitis].
Kobayashi
H
H
Third Clinical Department, Saitama Cancer Center Hospital.
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D006801:Humans; D008199:Lymphadenitis / Q000188:drug therapy / Q000469:parasitology*; D011739:Pyrimethamine / Q000627:therapeutic use; D015572:Spiramycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013422:Sulfamonomethoxine / Q000627:therapeutic use; D014123:Toxoplasmosis
D000890:Anti-Infective Agents; D000981:Antiprotozoal Agents; C033163:acetylspiramycin; D013411:Sulfadiazine; D015572:Spiramycin; D013422:Sulfamonomethoxine; D011739:Pyrimethamine